A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Condition(s) studied
Investigational drug(s) / intervention(s)
Orforglipron: Administered orally
Placebo: Administered orally
Study summary
The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.
Eligibility
Primary outcome measure(s)
- Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score — Baseline, Week 72
Trial sites (88)
| Facility | City | Region | Status |
|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | |
| AMR Clinical | Tempe | Arizona | |
| Care Access - Huntington Beach | Huntington Beach | California | |
| Care Access - Thousand Oaks | Thousand Oaks | California | |
| Legacy Clinical Trials | Colorado Springs | Colorado | |
| Chase Medical Research, LLC | Waterbury | Connecticut | |
| Care Access - Decatur | Decatur | Georgia | |
| North Georgia Clinical Research | Woodstock | Georgia | |
| Northwestern University | Chicago | Illinois | |
| AMR Clinical | Newton | Kansas | |
| MedVadis Research Corporation | Waltham | Massachusetts | |
| StudyMetrix Research | City of Saint Peters | Missouri | |
| AMR Clinical | Kansas City | Missouri | |
| Cardio Metabolic Institute | Somerset | New Jersey | |
| Carolina Research Center | Shelby | North Carolina | |
| University Orthopedics Center | Altoona | Pennsylvania | |
| Care Access - Rapid City | Rapid City | South Dakota | |
| AMR Clinical | Knoxville | Tennessee | |
| Mercy Family Clinic | Dallas | Texas | |
| Juno Research | Houston | Texas | |
| Biopharma Informatic, LLC | Houston | Texas | |
| Activian Clinical Research | Kingwood | Texas | |
| Advanced Rheumatology of Houston - Woodlands | The Woodlands | Texas | |
| Charlottesville Medical Research | Charlottesville | Virginia | |
| Gershon Pain Specialists | Virginia Beach | Virginia | |
| Northwest Clinical Research Center | Bellevue | Washington | |
| Aggarwal and Associates Limited | Brampton | Canada | |
| Diex Recherche Inc. Division Joliette | Joliette | Canada | |
| Your Research Network | Niagara Falls | Canada | |
| G.R.M.O. (Groupe de recherche en maladies osseuses) Inc. | Québec | Canada | |
| Alpha Recherche Clinique | Québec | Canada | |
| ALPHA Recherche Clinique | Québec | Canada | |
| Bluewater Clinical Research Group Inc. | Sarnia | Canada | |
| Winterberry Research Inc. | Stoney Creek | Canada | |
| The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technolo -T | Baotou | China | |
| Xuanwu Hospital Capital Medical University | Beijing | China | |
| The Second Affiliated Hospital Chongqing Medical University | Chongqing | China | |
| The Fourth Affiliated Hospital of Harbin Medical University | Harbin | China | |
| The Second People's Hospital of Hefei | Hefei | China | |
| Jinan Central Hospital | Jinan | China |
+ 48 more sites — see the full list on the official registry below.
More Eli Lilly and Company trials in Mexico
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07153471 on ClinicalTrials.gov ↗ ← All trials in Mexico